Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Caux

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 29, 2022
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patientsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotypeEmilie Plantamura, Amiran Dzutsev, Mathias Chamaillard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammationMichael Gombert, Marie-Caroline Dieu-Nosjean, Franziska Winterberg, et al.
Journal for Immunotherapy of Cancer|October 12, 2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cellsBeatris Mastelic-Gavillet, Blanca Navarro Rodrigo, Laure Décombaz, et al.
Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
The Journal of Experimental Medicine|April 2, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancerGuilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, et al.
Cancers|March 10, 2022
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 TrialJean-David Fumet, Emilie Lardenois, Isabelle Ray-Coquard, et al.
Nature Communications|July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2022
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancerSandra Ortiz-Cuaran, Aurélie Swalduz, Jean-Philippe Foy, et al.
The Journal of Allergy and Clinical Immunology|April 6, 2015
PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunityAnne-Laure Mathieu, Estelle Verronese, Gillian I Rice, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|August 29, 2022
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patientsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotypeEmilie Plantamura, Amiran Dzutsev, Mathias Chamaillard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammationMichael Gombert, Marie-Caroline Dieu-Nosjean, Franziska Winterberg, et al.
Journal for Immunotherapy of Cancer|October 12, 2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cellsBeatris Mastelic-Gavillet, Blanca Navarro Rodrigo, Laure Décombaz, et al.
Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
The Journal of Experimental Medicine|April 2, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancerGuilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, et al.
Cancers|March 10, 2022
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 TrialJean-David Fumet, Emilie Lardenois, Isabelle Ray-Coquard, et al.
Nature Communications|July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2022
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancerSandra Ortiz-Cuaran, Aurélie Swalduz, Jean-Philippe Foy, et al.
The Journal of Allergy and Clinical Immunology|April 6, 2015
PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunityAnne-Laure Mathieu, Estelle Verronese, Gillian I Rice, et al.
Pageof 15